Page 80 - Age Groups News Today

This is not the efficacy data, as it were. this isnt 95% against preventing infection. do they need that before they apply for emergency use authorization? whats next here? >> yeah. thats a great point. so i think a couple things. one, as you know, the vaccine itself has been already approved. just as you said, in order to expedite this process, they will likely approve for emergency use authorization with the data that shows that it is safe and seems to generate these antibodantibo. they are co...

>> explaining how and why most vaccines we give are at least three doses and this will follow the same pattern, and that could have better set expectations. >> reporter: government officials and medical experts presented in-depth data to the committee including findings out of israel indicating boosters are effective in reducing risk of severe illness in high-risk age groups. however, members felt there wasnt enough evidence to support boosters for younger people. do you worry this debate over b...

Nach den Impfquoten klaffen auch die Wochen-Inzidenzen zwischen Ost- und Westdeutschland auseinander. Ist das mehr als ein Schulbeginn-Effekt?

In der Corona-Pandemie zeigt sich ein weiteres deutliches Ost-West-Gefälle: Die 7-Tages-Inzidenz, die im Labor bestätigte Neuinfektionen pro 100.000 Einwohner...

BERLIN (dpa-AFX) - In der Corona-Pandemie zeigt sich ein weiteres deutliches Ost-West-Gefälle: Die 7-Tages-Inzidenz, die im Labor bestätigte Neuinfektionen pro 100 000 Einwohner binnen einer Woche anzeigt

Lets say theyre confused because theyre seeing so many questions being thrown at it and people just want a clear answer, yes or no. think the answer is yes for age groups, probably not for every single american. but the unfortunately were going to probably draw a bright line and recommend it, looks like well likely recommend it for 16 and above based on the application. i think thats where the interesting conversations will occur today. >> yeah. doctor, it is hard to understand why it is so conf...

Varies with u.s. data. u.s. data shows protection against serious illness remains high through delta and for all age groups, which is different from what the israelis are finding, so we didnt follow their lead. >> you also said, doctor, that the biden administration rushed the booster approval process. but can you explain why you feel this was moved too quickly? >> all right. well, the way the process works is to identify a problem. you pose a solution to the problem, which in this case would be...

Free from illness or anything that could get them into a hospital situation which are inundated? is there an acknowledgement of this moment, this crisis in public health in the country? >> this was posed in a different way, nicolle. what is the public health impact on transmission, decreasing transmission for boosters and theres not enough evidence. israel suggested, look, our cases all came down in all age groups because were reducing that, thats inference. the cdc representative was asked this...

60 and older who are medically frail but ideally allowing boosters for others who want them and who want that extra layer of protection i think would be a really reasonable and welcome step. >> so sanjay, obviously a lot of the data, as it always has during this pandemic, has come from israel. can you just talk about why that is? i think its because of the deal they made with pfizer in order to get vaccines they would provide a lot of data and access. but is data are from israel, does that apply...

Vaccines, they would provide data and access. is data from israel -- does that apply to whats going on in the u.s.? they have a higher vaccination rate and smaller population. i dont know if that matters. >> i think its valuable. its not perfect. but i think they are ahead of us in terms of vaccinations, 63% of the country is vaccinated. they started off strong. its been interesting to follow their data. they started boosting. they have been boosting really since august. they are doing younger a...